Geneve, Geneva, Switzerland Eclosion SA appeared to be the VC, which was created in 2001. The venture was found in Europe in Switzerland. The main department of described VC is located in the Geneva.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Eclosion SA, startups are often financed by Vesalius Biocapital Partners, MP Healthcare Venture Management, Andera Partners. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, Andera Partners, MP Healthcare Venture Management. In the next rounds fund is usually obtained by M Ventures, Vesalius Biocapital Partners, Andera Partners.
Among the most popular portfolio startups of the fund, we may highlight Genkyotex, Calypso Biotech. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical, Pharmaceutical.
The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2013. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Eclosion SA works on 2 percentage points less the average amount of lead investments.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Changzhou Investment Group Co Ltd | Changzhou, China, Zhejiang |
| Daiko Denshi Tsushin | Japan, Tokyo |
| Huntington Ingalls Industries | Newport News, United States, Virginia |
| Huoban Chuangtou | Beijing, China, Haidian |
| IFM Investors | Australia, Melbourne, Victoria |
| Japan Growth Investment Alliance | Japan, Tokyo |
| KnowledgeNet Holdings | Ar Riyad, Riyadh, Saudi Arabia |
| KP Partners | - |
| LinkMe Mobile | - |
| Migration Capital | - |
| Mindata | China, Guangdong, Shenzhen |
| Multi-Health Systems | Canada, Ontario, Toronto |
| Seaya Ventures | Madrid, Madrid, Spain |
| Semapa Next | Lisboa, Lisbon, Portugal |
| Sequoia Consulting | California, San Mateo, United States |
| Strada Education Network | Indiana, Indianapolis, United States |
| Vereeni Investments | - |
| Vira Ventures | Argentina, Buenos Aires, Distrito Federal |
| Yahui Investment | - |
| YMCI Group | China, Kunming, Yunnan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
KYLYS | 01 Jan 2018 | Geneva, Switzerland | |||
Chord Therapeutics | 01 Jan 2015 | Geneva, Switzerland | |||
Geneva Biotech Center | 01 Jan 2014 | Geneva, Switzerland | |||
Calypso Biotech | $2M | 05 Mar 2013 | Geneva, Switzerland | ||
ObsEva | 01 Jan 2013 | Geneva, Switzerland | |||
Genkyotex | $27M | 09 Jul 2012 | Geneva, Geneva, Switzerland | ||
Genkyotex | $20M | 24 May 2011 | Geneva, Geneva, Switzerland | ||
Genkyotex | $1M | 30 Jan 2006 | Geneva, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
KYLYS | 01 Jan 2018 | Geneva, Switzerland | |||
Chord Therapeutics | 01 Jan 2015 | Geneva, Switzerland | |||
Geneva Biotech Center | 01 Jan 2014 | Geneva, Switzerland | |||
Calypso Biotech | $2M | 05 Mar 2013 | Geneva, Switzerland | ||
ObsEva | 01 Jan 2013 | Geneva, Switzerland | |||
Genkyotex | $27M | 09 Jul 2012 | Geneva, Geneva, Switzerland | ||
Genkyotex | $20M | 24 May 2011 | Geneva, Geneva, Switzerland | ||
Genkyotex | $1M | 30 Jan 2006 | Geneva, Switzerland |
